Abstract. Polyurethane prodrugs with different drug contents were synthesized using polycaprolactone, hexamethylene diisocyanate and ciprofloxacin. The thermal analysis of the materials was carried out by DSC and TG. Results showed that the crystallinity of the materials reduced as the drug contents increased and the materials were thermostable to be sterilized for the medical use.
Introduction
Polyurethane (PU) is a kind of polymer materials synthesized by macromolecular polyol, isocyanate and chain extender like glycol or diamine. Polyol is called soft segment (SS), while the combination of isocyanate and chain extender is called hard segment(HS). Neighbouring HSs associate with each other because of their large cohesive energy and form a domain. The domains are dispersed in the SS. This phenomenon is so-called microphase separation. The situation of microphase separation directly impacts the physical and mechanical performance of PU materials. The HS's and SS's structure, the content of HS and the thermal history of PU are considered as main factors that affect the situation of micphase separation in PU.
PU prodrug(CFPU) was synthesized using polycaprolactone(PCL1250), hexamethylene diisocyanate(HDI) and ciprofloxacin(CF) as chain extender. The influence of drug content on the thermodynamic properties of PU prodrug was studied by Differential scanning calorimetry analysis(DSC) and thermogravimetric analysis(TG). Drug content is not only relevant to the HS content, but also an important indicator of PU prodrug. So the drug content is a substitution of HS content to be considered.
Experiment
Reagents and raw materials. Polycaprolactone diol (PCL), average weight 1250, and 1, 6-hexane diisocyanate (HDI) were obtained from the Aldrich Chemical Company. Ciprofloxacin hydrochloride (CF) powder was supplied by Jingxin Pharm. (Xinchang, Zhejiang, China) Dimethylsulphoxide (DMSO), tetrahydrofuran (THF), N, N-dimethylformamide (DMF), dibutyltin dilaurate (DBTDL) and triethylamine (TEA) were all gained from Sinopharm Chemical Reagent CO. , Ltd. PU prodrug synthesis. The drug polymer was synthesized via a two-step solution polymerization reaction. The stoichiometry of the polymerization is 1: 0.66: 0.34 of HDI: PCL: CF.
Prepolymerization. PCL was dissolved and stirred in 50 mL DMSO at 60°C in a three-neck flask. The whole system was in a dehydrated nitrogen atmosphere. Then equimolar HDI and two droplets of DBTDL were added into the solution. The reaction took 3h.
Chain Extension. After prepolymerization, CF was added into the solution and TEA was added to neutralize the hydrochloric acid contained in the CF. HDI, with equal molar ratio to CF, was added subsequently. The solution was stirred at 60°C for 24h.
Eventually, the reaction was ended by the addition of 5mL methanol and stirred for another hour to terminate the residual -NCO group. The reagent was cooled down and precipitated in a mixture of ether and distilled water. The precipitate was stirred in distilled water for over 3 days, while the water -2015) was intermittently changed each day. The polymer was dried in a convection oven at 40°C for 24h, and subsequently vacuum dried at 40°C for another 24h. Drug contents of the prodrugs. Tab.1 shows the drug contents of CFPUs.
Tab.1 molar ratio of raw materials and drug contents of CFPUs
Characterization. The DSC-TG analysis was carried out by STA449C, NETZSCH. The heating rate was 10°C/min. The carrier gas was argon argon, 30mL/min.
Results and discussion
DSC analysis of CFPU. Different drug content means different SS/HS ratio, which affects glass transition temperature (Tg) and melt temperature(Tm) of PU prodrug. Fig.1 shows DSC curves of CFPU samples and PCL-1250. It's known that PCL's Tg and Tm temperature is about -60°C and 60°C, respectively. PCL has a superior crystallinity, which is weakened by microphase separation in CFPU because of the existence of hard segment. That makes the Tg and Tm of CFPUs different from PCL. Fig.1 compared DSC curves of PCL-1250 and CFPUs with various drug contents. CFPU-1 was blank PU that contains no CF. It can be seen that PCL melt at 52.5°C and CFPUs had two endothermic peaks. Since the PCL's Tg is about -60°C and Tm as Fig.1 shows was 52.5°C, it could be concluded that peaks at 41.5, 43, 46.5°C were HS's glass transition peaks. Temperature at about 41°C is the Tg temperature of HS. The contents of HS increased as the drug contents increased. Fig. 1 shows that the melt peaks of PCL(SS) weakened as the HS contents increased, the Tm of SS and Tg of HS also increased. The melt peaks of SS weakened means that crystallinity of CFPU reduced, which makes CFPU tensile and flexible. TG and DTG analysis of CFPU. CFPU was designed for in vivo use. High temperature sterilization is a typical way to sterilize materials for in vivo use. Typically, the temperature use to sterilize biomedical materials is among 110~200°C. So CFPUs is supposed to be thermostable at about 200°C. Fig.3 showed that CFPU3 and CFPU4 began to decompose at about 300°C. This means CFPUs were thermostable to be sterilized by heat or high temperature steam.
Conclusion
A series of CFPUs were synthesized via two-step solution polymerization. Thermodynamic analysis of CFPUs and PCL was carried out. DSC experiments showed that, the crystallinity of CFPU reduced as the drug content increased. That makes CFPU more tensile and flexible. TG and DTG analysis confirmed that the material is thermostable and can be sterilized by high temperature sterilization to be used for medical use.
